These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10721042)

  • 1. A placebo-controlled study of the effects of L-tryptophan in patients with premenstrual dysphoria.
    Steinberg S; Annable L; Young SN; Liyanage N
    Adv Exp Med Biol; 1999; 467():85-8. PubMed ID: 10721042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria.
    Steinberg S; Annable L; Young SN; Liyanage N
    Biol Psychiatry; 1999 Feb; 45(3):313-20. PubMed ID: 10023508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.
    Steiner M; Steinberg S; Stewart D; Carter D; Berger C; Reid R; Grover D; Streiner D
    N Engl J Med; 1995 Jun; 332(23):1529-34. PubMed ID: 7739706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial.
    Sundblad C; Hedberg MA; Eriksson E
    Neuropsychopharmacology; 1993 Sep; 9(2):133-45. PubMed ID: 8216696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome.
    Halbreich U; Smoller JW
    J Clin Psychiatry; 1997 Sep; 58(9):399-402. PubMed ID: 9378691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tryptophan in the treatment of late luteal phase dysphoric disorder: a pilot study.
    Steinberg S; Annable L; Young SN; Bélanger MC
    J Psychiatry Neurosci; 1994 Mar; 19(2):114-9. PubMed ID: 8204563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial.
    Sundblad C; Modigh K; Andersch B; Eriksson E
    Acta Psychiatr Scand; 1992 Jan; 85(1):39-47. PubMed ID: 1546547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placebo-controlled trial comparing intermittent and continuous paroxetine in premenstrual dysphoric disorder.
    Landén M; Nissbrandt H; Allgulander C; Sörvik K; Ysander C; Eriksson E
    Neuropsychopharmacology; 2007 Jan; 32(1):153-61. PubMed ID: 17035933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries.
    Cohen LS; Miner C; Brown EW; Freeman E; Halbreich U; Sundell K; McCray S
    Obstet Gynecol; 2002 Sep; 100(3):435-44. PubMed ID: 12220761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder.
    Halbreich U; Bergeron R; Yonkers KA; Freeman E; Stout AL; Cohen L
    Obstet Gynecol; 2002 Dec; 100(6):1219-29. PubMed ID: 12468166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mood and performance changes in women with premenstrual dysphoric disorder: acute effects of alprazolam.
    Evans SM; Haney M; Levin FR; Foltin RW; Fischman MW
    Neuropsychopharmacology; 1998 Dec; 19(6):499-516. PubMed ID: 9803426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomized, double-blind, placebo-controlled crossover trial.
    Young SA; Hurt PH; Benedek DM; Howard RS
    J Clin Psychiatry; 1998 Feb; 59(2):76-80. PubMed ID: 9501889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study.
    Wang M; Hammarbäck S; Lindhe BA; Bäckström T
    Acta Obstet Gynecol Scand; 1995 Nov; 74(10):803-8. PubMed ID: 8533564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group.
    Thys-Jacobs S; Starkey P; Bernstein D; Tian J
    Am J Obstet Gynecol; 1998 Aug; 179(2):444-52. PubMed ID: 9731851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromocriptine and premenstrual tension: a clinical and hormonal study.
    Andersch B; Hahn L
    Pharmatherapeutica; 1982; 3(2):107-13. PubMed ID: 7201645
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Sato A; Fukawa-Nagira A; Sashihara T
    Nutrients; 2023 Dec; 15(23):. PubMed ID: 38068843
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute tryptophan depletion aggravates premenstrual syndrome.
    Menkes DB; Coates DC; Fawcett JP
    J Affect Disord; 1994 Sep; 32(1):37-44. PubMed ID: 7798465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premenstrual syndrome: a double-blind controlled trial of progesterone and placebo.
    Sampson GA
    Br J Psychiatry; 1979 Sep; 135():209-15. PubMed ID: 385093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paroxetine as a treatment for premenstrual dysphoric disorder.
    Yonkers KA; Gullion C; Williams A; Novak K; Rush AJ
    J Clin Psychopharmacol; 1996 Feb; 16(1):3-8. PubMed ID: 8834412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of premenstrual syndrome with alprazolam: results of a double-blind, placebo-controlled, randomized crossover clinical trial.
    Smith S; Rinehart JS; Ruddock VE; Schiff I
    Obstet Gynecol; 1987 Jul; 70(1):37-43. PubMed ID: 3299178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.